First Tracks Biotherapeutics, Inc. (TRAX)

NASDAQ: TRAX · Real-Time Price · USD

47.78

+5.91 (14.12%)

At close: Jul 30, 2026, 4:00 PM EDT

47.53

-0.25 (-0.52%)

After-hours: Jul 30, 2026, 7:41 PM EDT

TRAX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cost of Revenue	139.61	139.61	152.35	-
Gross Profit	-139.61	-139.61	-152.35	-
Selling, General & Admin	48.43	39.39	28.76	20.87
Research & Development	-7.51	-	-	90.26
Operating Expenses	40.92	39.39	28.76	111.12
Operating Income	-180.54	-179.01	-181.1	-111.12
Interest & Investment Income	11.18	12.94	17.38	12.31
Other Non Operating Income (Expenses)	-0.02	-0.02	0.01	-0
EBT Excluding Unusual Items	-169.38	-166.09	-163.71	-98.81
Pretax Income	-169.38	-166.09	-163.71	-106.15
Net Income	-169.38	-166.09	-163.71	-106.15
Net Income to Common	-169.38	-166.09	-163.71	-106.15
Net Income Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-130.55	-143.01	-126.16	-93.81
EBITDA	-180	-178.45	-180.5	-110.47
D&A For EBITDA	0.54	0.56	0.61	0.65
EBIT	-180.54	-179.01	-181.1	-111.12